Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA



Deep Insight

CD47, a multi-facetted target for cancer immunotherapy
FOXP3 expression in tumor cells and its role in cancer progression
Inflammatory programming and immune modulation in cancer by IDO
Immune and non-immune surveillance in cancer
Insight in inflammation and cancer
Macrophages in human cancer: Current and future aspects
NK cell receptors: evolution and diversity
Th17 cells: inflammation and regulation
Intracellular tyrosine phosphatases and kinases in lymphoma


ACVR2A (Activin Receptor Type 2)
ATMIN (ATM Interactor)
AXL (AXL receptor tyrosine kinase)
BACH2 (BTB and CNC homology 1, basic leucine zipper transcription factor 2)
BAK1 (BCL2-antagonist/killer 1)
BCL2L14 (BCL2-like 14 (apoptosis facilitator))
BIN1 (Bridging Integrator 1)
BIRC8 (baculoviral IAP repeat containing 8)
BTK (Bruton agammaglobulinemia tyrosine kinase)
CASP8 (Caspase 8, Apoptosis-Related Cysteine Peptidase)
CBLB (Cas-Br-M (murine) ecotropic retroviral transforming sequence b)
CCR9 (chemokine (C-C motif) receptor 9)
CD22 (CD22 molecule)
CD2AP (CD2 associated protein)
CD38 (CD38 molecule)
CD47 (Cluster of Differentiation 47)
CD59 (CD59 molecule, complement regulatory protein)
CD74 (CD74 molecule, major histocompatibility complex, class II invariant chain)
CD81 (Cluster of Differentiation 81)
CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5 (carcinoembryonic antigen))
CEBPA (CCAAT/enhancer binding protein (C/EBP), alpha)
CLEC1B (C-Type Lectin Domain Family 1, Member B)
CLIC1 (chloride intracellular channel 1)
CPM (carboxypeptidase M)
CRLF2 (Cytokine receptor like factor 2)
CX3CL1 (chemokine (C-X3-C motif) ligand 1)
CXCL10 (chemokine (C-X-C motif) ligand 10)
CXCL12 (chemokine (C-X-C motif) ligand 12)
CXCL17 (chemokine (C-X-C motif) ligand 17)
CXCL5 (chemokine (C-X-C motif) ligand 5)
CXCR1 (chemokine (C-X-C motif) receptor 1)
CYLD (cylindromatosis (turban tumor syndrome))
DCD (dermcidin)
DDIT4 (DNA-damage-inducible transcript 4)
DEFB1 (defensin, beta 1)
DLG1 (discs, large homolog 1 (Drosophila))
DPP4 (dipeptidyl-peptidase 4)
DUSP10 (dual specificity phosphatase 10)
EDIL3 (EGF-Like Repeats And Discoidin I-Like Domains 3)
EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2)
ELF4 (E74-like factor 4 (ets domain transcription factor))
ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian))
ERVW-1 (Endogenous Retroviral family W, Env (C7), member 1)
FAP (fibroblast activation protein alpha)
FAS (Fas cell surface death receptor)
FAU (Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed)
FBLN1 (fibulin 1)
FCER2 (Fc fragment of IgE, low affinity II, receptor for (CD23))
FGFR4 (fibroblast growth factor receptor 4)
FMNL1 (formin like 1)
FOXP3 (forkhead box P3)
FPR1 (formyl peptide receptor 1)
FUT8 (fucosyltransferase 8 (alpha (1,6) fucosyltransferase))
GAS5 (growth arrest-specific 5 (non-protein coding))
GATA3 (GATA binding protein 3)
GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa)
GFI1B (growth factor independent 1B transcription repressor)
GFI1 (growth factor independent 1 transcription repressor)
GSK3B (glycogen synthase kinase 3 beta)
GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3))
HLA-G (major histocompatibility complex, class I, G)
HSPB8 (heat shock 22kDa protein 8)
ID2 (Inhibitor Of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein)
IDO1 (indoleamine 2,3-dioxygenase 1)
IDO2 (indoleamine 2,3-dioxygenase 2)
IGH (Immunoglobulin Heavy)
IGK (Immunoglobulin Kappa)
IGL (Immunoglobulin Lambda)
IL17A (interleukin 17A)
IL17F (interleukin 17F)
IL1B (interleukin 1, beta)
IL1RN (interleukin 1 receptor antagonist)
IL21R (interleukin 21 receptor)
IL22 (interleukin 22)
IL22RA1 (interleukin 22 receptor, alpha 1)
IL23A (interleukin 23, alpha subunit p19)
IL7R (interleukin 7 receptor)
IRF4 (interferon regulatory factor 4)
ITK (IL2-inducible T-cell kinase)
JAK1 (Janus kinase 1)
KDR (kinase insert domain receptor)/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
KLRK1 (killer cell lectin-like receptor subfamily K, member 1)
KSR1 (kinase suppressor of ras 1)
LCK (lymphocyte-specific protein tyrosine kinase)
LGALS3 (lectin, galactoside-binding, soluble, 3)
LPAR2 (lysophosphatidic acid receptor 2)
MALT1 (mucosa associated lymphoid tissue lymphoma translocation gene 1)
MICA (MHC class I polypeptide-related sequence A)
MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor))
RIOX2 (ribosomal oxygenase 2)
MIR146B (microRNA 146b)
MRC1 (mannose receptor, C type 1)
MST1 (macrophage stimulating 1 (hepatocyte growth factor-like))
NAMPT (nicotinamide phosphoribosyltransferase)
NCR2 (natural cytotoxicity triggering receptor 2)
NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13)
NR3C1 (nuclear receptor subfamily 3, group C, member 1/glucocorticoid receptor)
NT5E (5'-nucleotidase, ecto (CD73))
NUMB (numb homolog (Drosophila))
PAEP (progestagen-associated endometrial protein)
PASD1 (PAS domain containing 1)
PDCD5 (programmed cell death 5)
PF4 (platelet factor 4)
PF4V1 (Platelet Factor 4 Variant 1)
PIAS1 (protein inhibitor of activated STAT, 1)
PIAS3 (protein inhibitor of activated STAT, 3)
PIK3CD (phosphoinositide-3-kinase, catalytic, delta polypeptide)
PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid))
PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent))
PLCG1 (Phospholipase C, Gamma 1)
PML (promyelocytic leukemia)
PNP (Purine Nucleoside Phosphorylase)
PPARG (peroxisome proliferator-activated receptor gamma)
PRAME (Preferentially Expressed Antigen In Melanoma)
PTMA (prothymosin, alpha)
PTPN14 (protein tyrosine phosphatase, non-receptor type 14)
PYCARD (PYD and CARD domain containing)
RHOH (Ras homolog gene family, member H)
S100A7 (S100 calcium binding protein A7)
S100A8 (S100 calcium binding protein A8)
S100A9 (S100 calcium binding protein A9)
SASH1 (SAM and SH3 domain containing 1)
SEMA3B (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B)
SEMA4D (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D)
SGK1 (serum/glucocorticoid regulated kinase 1)
SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae))
SLPI (secretory leukocyte peptidase inhibitor)
SOCS2 (suppressor of cytokine signaling 2)
SYK (spleen tyrosine kinase)
TAC1 (tachykinin, precursor 1)
TRA (T cell Receptor Alpha)
TRB (T cell Receptor Beta)
TRD (T cell Receptor Delta)
TRG (T cell Receptor Gamma)
THBS1 (thrombospondin-1)
THY1 (Thy-1 cell surface antigen)
TNFRSF17 (tumor necrosis factor receptor superfamily, member 17)
TNFRSF9 (TNF receptor superfamily member 9)
TNFSF15 (tumor necrosis factor (ligand) superfamily, member 15)
TNFSF18 (tumor necrosis factor (ligand) superfamily, member 18)
TRIM27 (tripartite motif containing 27)
TRPV2 (transient receptor potential cation channel, subfamily V, member 2)
UBD (ubiquitin D)
VAV3 (vav 3 guanine nucleotide exchange factor)
WAS (Wiskott-Aldrich syndrome)
ZAP70 (zeta-chain (TCR) associated protein kinase 70kDa)


Figure from Autophagy

Figure from ATMIN

Figure from AXL

Figure from AXL

Figure from BAK1

Figure from BCL2L14

Figure from CD74

Figure from CEACAM5

Figure from CXCL12

Figure from CXCR1

Figure from CYLD

Figure from DPP4

Figure from EIF2AK2

Figure from ELF4

Figure from ELF4

Figure from ERBB3

Figure from FAS

Figure from FAS

Figure from FBLN1

Figure from FGFR4

Figure from FOXP3

Figure from FOXP3

Figure from FPR1

Figure from FUT8

Figure from GBP1

Figure from GFI1

Figure from GSK3B

Figure from HLA-G

Figure from HLA-G

Figure from HSPB8

Figure from HSPB8

Figure from IGH

Figure from IGK

Figure from IGL

Figure from IL17A

Figure from IL1RN

Figure from IL21R

Figure from IL21R

Figure from IL22RA1

Figure from IL22RA1

Figure from IL23A

Figure from ITK

Figure from KDR

Figure from KSR1

Figure from LCK

Figure from LPAR2

Figure from MALT1

Figure from MICA

Figure from MINA

Figure from MIR146B

Figure from MRC1

Figure from MST1

Figure from NDUFA13

Figure from NR3C1

Figure from NUMB

Figure from PF4

Figure from PIAS1

Figure from PIAS3

Figure from PIK3CD

Figure from PLA2G4A

Figure from PLCG1

Figure from PPARG

Figure from PTPN14

Figure from SASH1

Figure from SEMA3B

Figure from SEMA4D

Figure from SEMA4D

Figure from SGK1

Figure from TRA@

Figure from TRB@

Figure from TRD@

Figure from TRG@

Figure from THY1

Figure from TNFSF18

Figure from TRIM27

Figure from TRPV2

Figure from VAV3

Figure from VAV3

Figure from ZAP70


WrittenOct 2009Jean-Loup Huret
UpdatedJan 2021Jean-Loup Huret and Philippe Dessen


This paper should be referenced as such :
, Huret JL, Dessen P.. Immunity. Atlas Genet Cytogenet Oncol Haematol. Jan 2021 .

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jan 13 17:37:03 CET 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA